Assessment of the MRI Solution: KORA 100 and Beflex Pacing Leads System (IKONE)
Primary Purpose
Bradycardia
Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
MRI
Sponsored by
About this trial
This is an interventional other trial for Bradycardia focused on measuring Pacemaker, leads and MRI exam
Eligibility Criteria
Inclusion Criteria:
- Patient who is already implanted with following system KORA 100 (SR or DR) pacemaker and Beflex RF45D and/or RF46D pacing leads in the left or right pectoral region
- Patient who is able and willing out-of-chest non medical indicated MRI scanning OR patients with planned medical indicated out of chest MRI scanning
- Patient who fulfils MRI solutions conditions
- Patient who provides signed and dated informed consent
Exclusion Criteria:
- Implanted or planned to be implanted non MR-compatible device or material
- Permanent Atrial Fibrillation (for DR devices)
- Diaphragmatic/phrenic stimulation
- Claustrophobia
- Incessant ventricular tachyarrhythmia
- Inability to understand the purpose of the study or refusal to co-operate
- Unavailability for scheduled follow-ups at the implanting centre
- Already included in another clinical trial that could affect the results of this study
- Patient is minor (less than 18-years old)
- Patient is pregnant - Patient is forfeiture of freedom or under guardianship
Sites / Locations
- CHU Charles Nicolle
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
Pacemaker + leads
Arm Description
all patients must have a MRI exam after pacemaker implantation
Outcomes
Primary Outcome Measures
Measure the atrial and ventricular pacing thresholds in Volts before and after the MRI exam, using the programmer.
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02175797
Brief Title
Assessment of the MRI Solution: KORA 100 and Beflex Pacing Leads System
Acronym
IKONE
Official Title
Assessment of the MRI Solution: KORA 100 and Beflex Pacing Leads System
Study Type
Interventional
2. Study Status
Record Verification Date
April 2019
Overall Recruitment Status
Completed
Study Start Date
February 2014 (undefined)
Primary Completion Date
August 2014 (Actual)
Study Completion Date
August 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
MicroPort CRM
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to report the stability of atrial and ventricular leads by absence of effect of the MRI exam on the pacing and sensing threshold and to report the safety based on the serious adverse events.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Bradycardia
Keywords
Pacemaker, leads and MRI exam
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
33 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Pacemaker + leads
Arm Type
Other
Arm Description
all patients must have a MRI exam after pacemaker implantation
Intervention Type
Device
Intervention Name(s)
MRI
Intervention Description
at least 6 weeks after the implantation of the pacemaker a MRI exam is performed
Primary Outcome Measure Information:
Title
Measure the atrial and ventricular pacing thresholds in Volts before and after the MRI exam, using the programmer.
Time Frame
1 month
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patient who is already implanted with following system KORA 100 (SR or DR) pacemaker and Beflex RF45D and/or RF46D pacing leads in the left or right pectoral region
Patient who is able and willing out-of-chest non medical indicated MRI scanning OR patients with planned medical indicated out of chest MRI scanning
Patient who fulfils MRI solutions conditions
Patient who provides signed and dated informed consent
Exclusion Criteria:
Implanted or planned to be implanted non MR-compatible device or material
Permanent Atrial Fibrillation (for DR devices)
Diaphragmatic/phrenic stimulation
Claustrophobia
Incessant ventricular tachyarrhythmia
Inability to understand the purpose of the study or refusal to co-operate
Unavailability for scheduled follow-ups at the implanting centre
Already included in another clinical trial that could affect the results of this study
Patient is minor (less than 18-years old)
Patient is pregnant - Patient is forfeiture of freedom or under guardianship
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Arnaud Mr SAVOURE, cardiologist
Organizational Affiliation
CHU Charles Nicolle - 1 rue Germont, 76000 ROUEN
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHU Charles Nicolle
City
Rouen
ZIP/Postal Code
76000
Country
France
12. IPD Sharing Statement
Learn more about this trial
Assessment of the MRI Solution: KORA 100 and Beflex Pacing Leads System
We'll reach out to this number within 24 hrs